Literature DB >> 28509888

Cardiac Contractility Modulation: A Technical Guide for Device Implantation.

Jürgen Kuschyk1, Axel Kloppe2, Stephan Schmidt-Schweda3, Hendrik Bonnemeier4, Benny Rousso5, Susanne Röger1.   

Abstract

This article provides a technical description of common implant practice for delivery of cardiac contractility modulation (CCM) therapy to heart failure patients. As of September 2016, the authors of this article collectively have been involved with more than 400 system implantations in five medical centers, beginning with the advent of CCM therapy approximately 12 years ago. CCM therapy has been evaluated in a variety of studies, and was shown to be safe and effective and of benefit to patient quality of life and exercise capacity. As the use of CCM therapy continuously expands among medical centers in Europe, this article describes the technical and practical aspects of the implant procedure, and additional special technical cases based on our cumulative experience.

Entities:  

Mesh:

Year:  2017        PMID: 28509888     DOI: 10.3909/ricm0825

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  4 in total

Review 1.  [Cardiac contractility modulation for treatment of chronic heart failure].

Authors:  J Kuschyk; B Rudic; V Liebe; E Tülümen; M Borggrefe; I Akin
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-10-25

Review 2.  [Cardiac contractility modulation].

Authors:  J Kuschyk; B Rudic; M Borggrefe; I Akin
Journal:  Internist (Berl)       Date:  2018-10       Impact factor: 0.743

3.  A comprehensive individual patient data meta-analysis of the effects of cardiac contractility modulation on functional capacity and heart failure-related quality of life.

Authors:  Francesco Giallauria; Gianluigi Cuomo; Alessandro Parlato; Nirav Y Raval; Jürgen Kuschyk; Andrew Js Stewart Coats
Journal:  ESC Heart Fail       Date:  2020-07-23

Review 4.  Cardiac contractility modulation for the treatment of heart failure with reduced ejection fraction.

Authors:  Peysh A Patel; Ramesh Nadarajah; Noman Ali; John Gierula; Klaus K Witte
Journal:  Heart Fail Rev       Date:  2020-08-27       Impact factor: 4.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.